ES2154680T3 - Metodo para controlar el tamaño de los liposomas. - Google Patents

Metodo para controlar el tamaño de los liposomas.

Info

Publication number
ES2154680T3
ES2154680T3 ES94921494T ES94921494T ES2154680T3 ES 2154680 T3 ES2154680 T3 ES 2154680T3 ES 94921494 T ES94921494 T ES 94921494T ES 94921494 T ES94921494 T ES 94921494T ES 2154680 T3 ES2154680 T3 ES 2154680T3
Authority
ES
Spain
Prior art keywords
liposomes
size
controlling
particle size
mean particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94921494T
Other languages
English (en)
Inventor
Laura M Edgerly-Pflug
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Application granted granted Critical
Publication of ES2154680T3 publication Critical patent/ES2154680T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

UN PROCESO PARA PRODUCIR UNA POBLACION DE LIPOSOMAS QUE USA UN LIPIDO EN UN SISTEMA SOLVENTE DE FASE UNICA DONDE LOS LIPOSOMAS TIENEN UNA DIMENSION DE PARTICULA MEDIA DESEADA,CONSISTIENDO EL PROCESO EN LA PRUEBA DE LA DIMENSION DE UNA POBLACION DE LIPOSOMAS AÑADIENDO AL LIPIDO UNA CONCENTRACION DE SOLVENTE ELEGIDO PARA FORMAR LA DIMENSION DE PARTICULA MEDIA DESEADA.
ES94921494T 1993-07-08 1994-07-08 Metodo para controlar el tamaño de los liposomas. Expired - Lifetime ES2154680T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8874293A 1993-07-08 1993-07-08

Publications (1)

Publication Number Publication Date
ES2154680T3 true ES2154680T3 (es) 2001-04-16

Family

ID=22213183

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94921494T Expired - Lifetime ES2154680T3 (es) 1993-07-08 1994-07-08 Metodo para controlar el tamaño de los liposomas.

Country Status (11)

Country Link
US (1) US6596305B1 (es)
EP (1) EP0707472B1 (es)
JP (1) JP3479535B2 (es)
AT (1) ATE199640T1 (es)
CA (1) CA2166465C (es)
DE (1) DE69426884T2 (es)
DK (1) DK0707472T3 (es)
ES (1) ES2154680T3 (es)
GR (1) GR3035825T3 (es)
PT (1) PT707472E (es)
WO (1) WO1995001777A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001333A (en) * 1997-09-12 1999-12-14 See; Jackie R. Methods of preparing micro encapsulated agents for use in the detection of tumors by CT imaging
ATE272392T1 (de) * 1999-02-08 2004-08-15 Alza Corp Verfahren zur kontrolle der liposomengrösse
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
AU2003201569B2 (en) * 2002-01-21 2008-09-11 Vasogen Ireland Limited Pharmaceutically acceptable phosphate-glycerol carrying bodies
AU2003230600B2 (en) * 2002-03-05 2009-06-04 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
DE60334618D1 (de) 2002-06-28 2010-12-02 Protiva Biotherapeutics Inc Verfahren und vorrichtung zur herstellung von liposomen
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
US9198645B2 (en) * 2003-11-26 2015-12-01 The United States of America, as represented by the Secretary of Commerce of The National Institute of Standards and Technology Controlled vesicle self-assembly in continuous two phase flow microfluidic channels
US20050129750A1 (en) * 2003-12-15 2005-06-16 Yu-Fang Hu Process for producing liposome suspension and product containing liposome suspension produced thereby
US8784881B2 (en) * 2004-03-05 2014-07-22 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of diseases
US8715591B2 (en) * 2004-07-21 2014-05-06 The United States of America, as represented by the Secretary of Commerce, The National Institute of Standards and Technology Microfluidic apparatus to control liposome formation
CN103989633A (zh) * 2005-07-27 2014-08-20 普洛体维生物治疗公司 制造脂质体的系统和方法
CN101325947A (zh) * 2005-12-08 2008-12-17 惠氏公司 脂质体组合物
HUE029994T2 (en) 2005-12-08 2017-04-28 Insmed Inc Lipid-based preparations of antinfectants for the treatment of lung infections
US20080089927A1 (en) * 2006-04-06 2008-04-17 Vladimir Malinin Methods for Coacervation Induced Liposomal Encapsulation and Formulations Thereof
US20080268031A1 (en) * 2007-03-15 2008-10-30 Benjamin Johnson Therapeutic Treatment of Dermatologic Skin Disorders
EP2146692A1 (en) * 2007-03-19 2010-01-27 Fresenius Kabi Oncology Limited Proliposomal and liposomal compositions
US20100196455A1 (en) * 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US20110105995A1 (en) * 2008-01-16 2011-05-05 Zhu Ting F Uniform-sized, multi-drug carrying, and photosensitive liposomes for advanced drug delivery
US20090246234A1 (en) * 2008-04-01 2009-10-01 Benjamin Johnson Therapeutic Treatment Using Niacin for Skin Disorders
US20100081954A1 (en) * 2008-09-30 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and system to control pH in pulmonary tissue of a subject
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions
TWI410256B (zh) * 2010-01-07 2013-10-01 Nat Univ Tsing Hua 雙重乳化法製備微脂體之新型裝置
US10016389B2 (en) * 2011-01-05 2018-07-10 Livon Laboratories Method of making liposomes, liposome compositions made by the methods, and methods of using the same
US8642655B2 (en) 2011-03-09 2014-02-04 Benjamin Johnson Systems and methods for preventing cancer and treating skin lesions
GB201116248D0 (en) * 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
WO2013168167A1 (en) * 2012-05-10 2013-11-14 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
US20150272880A1 (en) 2012-05-21 2015-10-01 Insmed Incorporated Systems for treating pulmonary infections
US20140120157A1 (en) 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
BR112015012351A8 (pt) 2012-11-29 2019-10-01 Insmed Inc composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
CN106568831B (zh) * 2016-11-18 2019-07-23 武汉理工大学 一种用于检测磷酸肌醇的多孔膜材料及其制备与检测方法
US11260028B2 (en) * 2017-06-26 2022-03-01 Fordoz Pharma Corp. Nanosome formulations of aprepitant and methods and applications thereof
GB2581882B (en) * 2017-08-01 2023-03-29 Ankasa Regenerative Therapeutics Inc WNT compositions and methods of process from serum-free culturing conditions
CN111565833B (zh) * 2017-11-01 2023-04-07 国立大学法人大阪大学 用于制造具有期望的粒径的脂质颗粒的方法及装置的开发
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039285A (en) * 1975-10-10 1977-08-02 Ortho Diagnostics, Inc. Single sample method for determination of lipoprotein concentrations in blood
US4184849A (en) * 1977-12-05 1980-01-22 Technicon Instruments Corporation Mixed agglutination
US4529561A (en) 1978-03-24 1985-07-16 The Regents Of The University Of California Method for producing liposomes in selected size range
US4522803A (en) 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4588578A (en) 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
CA1237670A (en) 1983-05-26 1988-06-07 Andrew S. Janoff Drug preparations of reduced toxicity
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
US4721612A (en) 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
US4619895A (en) * 1984-05-10 1986-10-28 The Regents Of The University Of California Lipoprotein marker for hypertriglyceridemia
US5008050A (en) 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US5077056A (en) 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
GB8426264D0 (en) 1984-10-17 1984-11-21 Alcan Int Ltd Porous films
US4861580A (en) 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US5154930A (en) 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5082664A (en) 1987-05-22 1992-01-21 The Liposome Company, Inc. Prostaglandin-lipid formulations
DE3852037T2 (de) 1987-07-29 1995-03-23 Liposome Co Inc Verfahren zur trennung von teilchen nach grösse.
AU3564589A (en) 1988-05-17 1989-12-12 Liposome Technology, Inc. Preparation of uniform-size liposomes and other lipid structures
US4994213A (en) * 1988-05-17 1991-02-19 Liposome Technology, Inc. Method of preparing lipid structures
US5000887A (en) * 1988-05-17 1991-03-19 Liposome Technology, Inc. Preparation of uniform-size liposomes
US4927637A (en) 1989-01-17 1990-05-22 Liposome Technology, Inc. Liposome extrusion method
WO1990011780A1 (en) 1989-03-31 1990-10-18 The Regents Of The University Of California Preparation of liposome and lipid complex compositions

Also Published As

Publication number Publication date
JPH08512240A (ja) 1996-12-24
CA2166465A1 (en) 1995-01-19
WO1995001777A1 (en) 1995-01-19
DE69426884T2 (de) 2001-06-21
PT707472E (pt) 2001-07-31
DE69426884D1 (de) 2001-04-19
EP0707472A1 (en) 1996-04-24
JP3479535B2 (ja) 2003-12-15
US6596305B1 (en) 2003-07-22
GR3035825T3 (en) 2001-07-31
EP0707472B1 (en) 2001-03-14
DK0707472T3 (da) 2001-04-17
CA2166465C (en) 2003-10-14
ATE199640T1 (de) 2001-03-15

Similar Documents

Publication Publication Date Title
ES2154680T3 (es) Metodo para controlar el tamaño de los liposomas.
BR9407563A (pt) Composto e processo para a produçao continua do mesmo
MX9304649A (es) Procedimiento para producir 7-(sustituido)-9-[glicilo sustituido]-6-desmetil-6-desoxitetraciclinas.
CU22939A3 (es) Proceso para la síntesis de 1,3 dioles
PL287150A1 (en) Method of obtaining pleuromutilin
AU5115493A (en) Method of obtaining 10-deacetylbaccatine iii
ES2089416T3 (es) Procedimiento de produccion de intermedios para uso en la produccion de alcoxiiminoacetamidas.
ATE199709T1 (de) Verfahren zur herstellung von (+)compactin und (+)mevinolin derivaten mit beta-hydroxy-delta- lactonresten
ATA109993A (de) Verfahren zur herstellung von neuen polypropylenendurch chemische degradierung
ES2058191T3 (es) Acidos 2-fenil-4-quinolincarboxilicos substituidos.
MX9302076A (es) Proceso novedoso para preparar derivados de piperidina.
MX9300395A (es) Derivados de oxazolina y proceso para su produccion
ES2080296T3 (es) Procedimiento para la preparacion de vinil eteres.
IS4038A (is) Aðferð til að framleiða olíukennda blöndu
DK0619305T3 (da) Lactonforbindelse og fremgangsmåde til fremstilling deraf
MX9301850A (es) Procedimiento para producir un tinte monoazo
AU1646195A (en) Method for favouring the production of effluents of a producing zone
DK0402322T3 (da) Fremgangsmåde til fremstilling af R(+)-aminocarnitin og S(-)-aminocarnitin
ES2045215T3 (es) (+)-o (+)-1-(2-n-aminoetil sustituido) -1-metil-7-metoxi-1,2,3,4-tetrahidronaftaleno, y procedimiento para su produccion.
AU2139792A (en) Method for production of 2-amino-6-halogenopurine and synthesis intermediate therefor
PL295277A1 (en) Method of obtaining 7-alpha-aminoacyl cephalosporines
FR2690272B1 (fr) Procédé de production de dispositifs émetteurs de champ commandables.
ATE175957T1 (de) Verfahren zur herstellung von alkoxyiminoacetamid-verbindungen
DK0640095T3 (da) Fremgangsmåde til fremstilling af vancomycin
PT97116A (pt) Processo para modular a producao de metabolitos secundarios nomeadamente derivados de beta-lactama

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 707472

Country of ref document: ES